Treatment of leukemia and lymphoma:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier, Acad. Press
2004
|
| Schriftenreihe: | Advances in pharmacology
51 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVII, 393 S. Ill., graph. Darst. |
| ISBN: | 0120329522 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV019640014 | ||
| 003 | DE-604 | ||
| 005 | 20080421 | ||
| 007 | t | ||
| 008 | 041221s2004 ad|| |||| 00||| eng d | ||
| 020 | |a 0120329522 |9 0-12-032952-2 | ||
| 035 | |a (OCoLC)56826601 | ||
| 035 | |a (DE-599)BVBBV019640014 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC643 | |
| 050 | 0 | |a RM30 | |
| 082 | 0 | |a 616.99419 |2 22 | |
| 245 | 1 | 0 | |a Treatment of leukemia and lymphoma |c ed. by David A. Scheinberg ... |
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier, Acad. Press |c 2004 | |
| 300 | |a XVII, 393 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in pharmacology |v 51 | |
| 650 | 4 | |a Leucémie | |
| 650 | 4 | |a Lymphome | |
| 650 | 4 | |a Sang - Maladies - Traitement | |
| 650 | 4 | |a Blood |x Diseases |x Treatment | |
| 650 | 4 | |a Leukemia | |
| 650 | 4 | |a Leukemia |x drug therapy | |
| 650 | 4 | |a Lymphoma |x drug therapy | |
| 650 | 4 | |a Lymphomas | |
| 700 | 1 | |a Scheinberg, David A. |e Sonstige |4 oth | |
| 830 | 0 | |a Advances in pharmacology |v 51 |w (DE-604)BV002534644 |9 51 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012968917&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012968917 | ||
Datensatz im Suchindex
| _version_ | 1804133011557449728 |
|---|---|
| adam_text | PV-I-H TREATMENT OF LEUKEMIA AND LYMPHOMA EDITED BY DAVID A. SCHEINBERG
MOLECULAR PHARMACOLOGY AND CHEMISTRY PROGRAM EXPERIMENTAL THERAPEUTICS
CENTER LEUKEMIA SERVICE MEMORIAL SLOAN-KETTERING CANCER CENTER NEW YORK,
NEW YORK JOSEPH G. JURCIC LEUKEMIA SERVICE DEPARTMENT OF MEDICINE
MEMORIAL SLOAN-KETTERING CANCER CENTER NEW YORK, NEW YORK ADVANCES IN
PHARMACOLOGY VOLUME 51 ELSEVIER ACADEMIC PRESS AMSTERDAM * BOSTON *
HEIDELBERG * LONDON NEW YORK * OXFORD * PARIS * SAN DIEGO SAN FRANCISCO
* SINGAPORE * SYDNEY * TOKYO CONTENTS CONTRIBUTORS XI PREFACE XV KINASE
INHIBITORS IN LEUKEMIA MARK LEVIS AND DONALD SMALL I. CHAPTER OVERVIEW 1
II. INTRODUCTION 2 III. FACTORS IN IDENTIFYING AN IDEAL THERAPEUTIC
TARGET 2 IV. KINASE TARGETS IN LEUKEMIA: CURRENT TREATMENT OPTIONS V.
KINASE TARGETS IN LEUKEMIA: ON THE HORIZON 14 VI. CONCLUSIONS 20
REFERENCES 20 THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA STEVEN SOLGNET AND
PETER MASLAK I. CHAPTER OVERVIEW 35 II. INTRODUCTION 35 III. DISEASE
BACKGROUND AND BIOLOGY 36 VI CONTENTS IV. TREATMENT APPROACHES 38
REFERENCES 52 INVESTIGATIONAL AGENTS IN MYELOID DISORDERS FARHAD RAVANDI
AND JORGE CORTES I. CHAPTER OVERVIEW 59 II. INTRODUCTION 60 III.
NUCLEOSIDE ANALOGS 60 IV. REVERSAL OF MULTIDRUG RESISTANCE 66 V.
BIOLOGICAL AGENTS 68 VI. SIGNALING MODULATORS 74 VII. CONCLUSIONS 82
REFERENCES 82 METHODOLOGIC ISSUES IN INVESTIGATION OF TARGETED THERAPIES
IN ACUTE MYELOID LEUKEMIA ELIHU ESTEY I. CHAPTER OVERVIEW 99 II.
INTRODUCTION 99 III. PATIENT SELECTION FOR TARGETED THERAPY TRIALS IN
ACUTE MYELOID LEUKEMIA 100 IV. ENDPOINTS FOR CLINICAL TRIALS OF TTS IN
AML 102 V. NEED FOR RANDOMIZED TRIALS OF TTS AND A PROPOSED STATISTICAL
DESIGN 103 REFERENCES 106 PURINE ANALOGS IN LEUKEMIA NICOLE LAMANNA AND
MARK WEISS I. CHAPTER OVERVIEW 107 II. INTRODUCTION 107 III. MECHANISMS
OF ACTION 108 IV. PURINE ANALOGS IN CHRONIC LYMPHOCYTIC LEUKEMIA 110 V.
PURINE ANALOGS IN HAIRY CELL LEUKEMIA 114 VI. PURINE ANALOGS IN ACUTE
MYELOID LEUKEMIA 114 VII. PURINE ANALOGS IN CHRONIC MYELOID LEUKEMIA 116
VIII. PURINE ANALOGS IN ALLOGENEIC STEM CELL TRANSPLANTATION 117 IX.
CONCLUSION AND FUTURE DIRECTIONS 118 REFERENCES 118 CONTENTS VII
MONOCLONAL ANTIBODY THERAPY IN LYMPHOID LEUKEMIAS THOMAS S. LIN AND JOHN
C. BYRD I. CHAPTER OVERVIEW 127 II. INTRODUCTION 128 III. CHRONIC
LYMPHOCYTIC LEUKEMIA 130 IV. T-CELL PROLYMPHOCYTIC LEUKEMIA 152 V. HAIRY
CELL LEUKEMIA 153 VI. CONCLUSIONS 155 REFERENCES 156 NATIVE ANTIBODY AND
ANTIBODY-TARGETED CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA ERIC L.
SIEVERS I. CHAPTER OVERVIEW 169 II. INTRODUCTION 170 III. LINGERING
QUESTIONS REGARDING IMMUNOCONJUGATE THERAPIES 178 IV. SUMMARY 180
REFERENCES 181 RADIOIMMUNOTHERAPY OF LEUKEMIA JOHN M. BURKE AND JOSEPH
G. JURCIC I. CHAPTER OVERVIEW 185 II. INTRODUCTION 186 III. ANTIGENIC
TARGETS 186 IV. RADIOISOTOPE SELECTION 187 V. RADIOLABELING 190 VI.
PHARMACOKINETICS AND DOSIMETRY 193 VII. RADIOIMMUNOTHERAPY WITH
/3-PARTICLE EMITTERS 194 VIII. RADIOIMMUNOTHERAPY WITH A-PARTICLE
EMITTERS 199 IX. SUMMARY 202 REFERENCES 203 IMMUNOTOXINS AND TOXIN
CONSTRUCTS IN THE TREATMENT OF LEUKEMIA AND LYMPHOMA MICHAEL ROSENBLUM
I. CHAPTER OVERVIEW 209 II. INTRODUCTION 209 VIII CONTENTS III. TARGETS
OF OPPORTUNITY IN LEUKEMIA AND LYMPHOMA 210 REFERENCES 221 ANTIBODY
THERAPY OF LYMPHOMA GEORGE J. WEINER AND BRIAN K. LINK I. CHAPTER
OVERVIEW 229 II. HISTORY 230 III. CHIMERIC ANTI-CD20*A CLINICAL
BREAKTHROUGH 232 IV. ALTERNATIVE MOLECULAR TARGETS 234 V. MECHANISMS OF
ACTION 236 VI. RADIOIMMUNOTHERAPY 241 VII. MABS COMBINED WITH
CHEMOTHERAPY 243 VIII. MABS COMBINED WITH IMMUNOTHERAPY 246 IX.
CONCLUSION 247 REFERENCES 248 VACCINES IN LEUKEMIA SIJIE LU, ERIC
WIEDER, KRISHNA KOMANDURI, QING MA, AND JEFFREY J. MOLLDREM I. CHAPTER
OVERVIEW 255 II. INTRODUCTION 256 III. POTENTIAL TARGET ANTIGENS 257 IV.
CLINICAL VACCINE TRIALS WITH LEUKEMIA-ASSOCIATED ANTIGENS 262 V.
CONCLUSION 264 REFERENCES 264 THERAPEUTIC IDIOTYPE VACCINES FOR
NON-HODGKIN S LYMPHOMA JOHN M. TIMMERMAN I. CHAPTER OVERVIEW 271 II.
INTRODUCTION 272 III. DEVELOPMENT OF THE IDIOTYPE VACCINE APPROACH 272
IV. RECOMBINANT IDIOTYPE VACCINES 278 V. PHASE III IDIOTYPE VACCINE
TRIALS 282 VI. PHARMACOLOGIC CONSIDERATIONS AND INTEGRATION WITH
STANDARD THERAPIES 283 VII. NEW AND ONGOING PHASE I/II CLINICAL TRIALS
OF IDIOTYPE VACCINATION 285 VIII. CONCLUSIONS AND FUTURE PROSPECTS 287
REFERENCES 288 CONTENTS IX CYTOKINE MODULATION OF THE INNATE IMMUNE
SYSTEM IN THE TREATMENT OF LEUKEMIA AND LYMPHOMA SHERIF S. FARAG AND
MICHAEL A. CALIGIURI I. CHAPTER OVERVIEW 295 II. INTRODUCTION 296 III.
EFFECTOR CELLS OF THE INNATE IMMUNE SYSTEM: RELEVANCE TO CYTOKINE
THERAPY 296 IV. CYTOKINE THERAPY: EXPLOITING INNATE IMMUNE EFFECTORS 302
V. NOVEL APPROACHES FOR THE IMMUNOMODULATION OF LEUKEMIA AND LYMPHOMA
306 VI. CONCLUSION 311 REFERENCES 311 DONOR LYMPHOCYTE INFUSIONS VINCENT
T. HO AND EDWIN P. ALYEA I. CHAPTER OVERVIEW 319 II. INTRODUCTION 319
III. GRAFT-VERSUS-LEUKEMIA: EXPERIMENTAL MODELS 320 IV. DONOR LYMPHOCYTE
INFUSIONS FOR CHRONIC MYELOID LEUKEMIA 321 V. MULTIPLE MYELOMA 324 VI.
MYELODYSPLASTIC SYNDROME AND ACUTE LEUKEMIA 326 VII. CHRONIC LYMPHOCYTIC
LEUKEMIA AND LYMPHOMA 327 VIII. EBV-ASSOCIATED LYMPHOPROLIFERATIVE
DISORDERS AFTER BONE MARROW TRANSPLANTATION 327 IX. COMPLICATIONS OF DLI
328 X. METHODS TO ENHANCE THE GVL RESPONSE AFTER DLI 330 XI. MEDIATORS
OF THE GVL EFFECT 330 XII. POTENTIAL TARGETS OF THE GVL EFFECT 332 XIII.
TUMOR-SPECIFIC TARGETS OF THE DLI/GVL RESPONSE 335 XIV. FUTURE
DIRECTIONS 336 REFERENCES 337 SOMATIC CELL ENGINEERING AND THE
IMMUNOTHERAPY OF LEUKEMIAS AND LYMPHOMAS RENIER J. BRENTJENS AND MICHEL
SADELAIN I. CHAPTER OVERVIEW 347 II. INTRODUCTION 348 X CONTENTS III.
IMMUNE EFFECTOR CELL ACTIVATION 350 IV. IMMUNIZATION AGAINST HEMATOLOGIC
MALIGNANCIES: TUMOR CELL VACCINES 351 V. IMMUNIZATION AGAINST
HEMATOLOGIC MALIGNANCIES: DENDRITIC CELL VACCINES 357 VI. ADOPTIVE
T-CELL THERAPY DIRECTED AGAINST HEMATOLOGIC MALIGNANCIES 359 VII.
CONCLUSION 362 REFERENCES 363 INDEX 371 CONTENTS OF PREVIOUS VOLUMES 383
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV019640014 |
| callnumber-first | R - Medicine |
| callnumber-label | RC643 |
| callnumber-raw | RC643 RM30 |
| callnumber-search | RC643 RM30 |
| callnumber-sort | RC 3643 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)56826601 (DE-599)BVBBV019640014 |
| dewey-full | 616.99419 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99419 |
| dewey-search | 616.99419 |
| dewey-sort | 3616.99419 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01447nam a2200421 cb4500</leader><controlfield tag="001">BV019640014</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080421 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041221s2004 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0120329522</subfield><subfield code="9">0-12-032952-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)56826601</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019640014</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC643</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM30</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99419</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of leukemia and lymphoma</subfield><subfield code="c">ed. by David A. Scheinberg ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier, Acad. Press</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 393 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in pharmacology</subfield><subfield code="v">51</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leucémie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sang - Maladies - Traitement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood</subfield><subfield code="x">Diseases</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukemia</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphoma</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphomas</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scheinberg, David A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in pharmacology</subfield><subfield code="v">51</subfield><subfield code="w">(DE-604)BV002534644</subfield><subfield code="9">51</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012968917&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012968917</subfield></datafield></record></collection> |
| id | DE-604.BV019640014 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:01:56Z |
| institution | BVB |
| isbn | 0120329522 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012968917 |
| oclc_num | 56826601 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XVII, 393 S. Ill., graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Elsevier, Acad. Press |
| record_format | marc |
| series | Advances in pharmacology |
| series2 | Advances in pharmacology |
| spelling | Treatment of leukemia and lymphoma ed. by David A. Scheinberg ... Amsterdam [u.a.] Elsevier, Acad. Press 2004 XVII, 393 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in pharmacology 51 Leucémie Lymphome Sang - Maladies - Traitement Blood Diseases Treatment Leukemia Leukemia drug therapy Lymphoma drug therapy Lymphomas Scheinberg, David A. Sonstige oth Advances in pharmacology 51 (DE-604)BV002534644 51 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012968917&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Treatment of leukemia and lymphoma Advances in pharmacology Leucémie Lymphome Sang - Maladies - Traitement Blood Diseases Treatment Leukemia Leukemia drug therapy Lymphoma drug therapy Lymphomas |
| title | Treatment of leukemia and lymphoma |
| title_auth | Treatment of leukemia and lymphoma |
| title_exact_search | Treatment of leukemia and lymphoma |
| title_full | Treatment of leukemia and lymphoma ed. by David A. Scheinberg ... |
| title_fullStr | Treatment of leukemia and lymphoma ed. by David A. Scheinberg ... |
| title_full_unstemmed | Treatment of leukemia and lymphoma ed. by David A. Scheinberg ... |
| title_short | Treatment of leukemia and lymphoma |
| title_sort | treatment of leukemia and lymphoma |
| topic | Leucémie Lymphome Sang - Maladies - Traitement Blood Diseases Treatment Leukemia Leukemia drug therapy Lymphoma drug therapy Lymphomas |
| topic_facet | Leucémie Lymphome Sang - Maladies - Traitement Blood Diseases Treatment Leukemia Leukemia drug therapy Lymphoma drug therapy Lymphomas |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012968917&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002534644 |
| work_keys_str_mv | AT scheinbergdavida treatmentofleukemiaandlymphoma |